What is Proov?
Proov was founded by Dr. Amy Beckley, an infertility veteran and PhD Scientist, who developed the company's core technology after experiencing personal challenges with infertility and recurrent miscarriages. The company's mission is to empower women by providing accessible and easy-to-use at-home hormone testing solutions. Proov aims to address issues like luteal phase defects, enabling women to proactively manage their reproductive health and fertility journeys. The company's commitment to science-backed innovation positions it as a key player in the rapidly evolving femtech landscape.
How much funding has Proov raised?
Proov has raised a total of $9.7M across 1 funding round:
Series A
$9.7M
Series A (2021): $9.7M with participation from Gingerbread Capital, Portfolia FemTech II Fund, SteelSky Ventures, WCC Partners, Hambrecht Ducera Growth Ventures, and Lightship Capital
Key Investors in Proov
Gingerbread Capital
Gingerbread Capital is dedicated to closing the funding gap for women-led ventures at early and growth stages, as well as supporting emerging funds led by women and diverse teams. The company invests in exceptional women founders across various sectors, including healthcare, consumer products, and education.
Portfolia FemTech II Fund
Undisclosed investor participating in the funding round.
SteelSky Ventures
SteelSky Ventures is a visionary venture fund focused on investing in companies that enhance access, care, and outcomes in women's health. With $73 million in assets under management, they support innovations across consumer health, digital health, and healthcare infrastructure.
What's next for Proov?
The recent major strategic investment signals a pivotal moment for Proov, likely enabling the company to accelerate its product development, expand its market reach, and enhance its technological capabilities. With a focus on empowering women through accessible hormone tracking, Proov is poised to further solidify its position in the femtech industry. Future growth may involve expanding its testing portfolio, forging strategic partnerships, and increasing consumer awareness around proactive reproductive health management. The company's trajectory suggests a strong emphasis on scaling its impact and continuing to innovate in women's health.
See full Proov company page
